{"transactions":[{"id":1759886,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":1,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":2,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":4,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T20:51:41.000Z","date":"2023-10-13","kind":"sale","planned":false,"acquired":false,"shares":1076841,"price":0.1038,"value":111776.0958,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001760460-23-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000008/primary_doc.xml","form_type":"4"}},{"id":1864010,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":4,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-07T21:21:26.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":134421,"price":0.83,"value":111569.43,"ownership":{"direct":true},"balance_after":1076841,"source":{"system":"sec-edgar","filing":"0001760460-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000006/primary_doc.xml","form_type":"4"}},{"id":1884752,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":3,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:55:49.000Z","date":"2023-05-18","kind":"sale","planned":false,"acquired":false,"shares":560000,"price":9.46,"value":5297600.0,"ownership":{"direct":true},"balance_after":1211262,"source":{"system":"sec-edgar","filing":"0001760460-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000003/primary_doc.xml","form_type":"4"}},{"id":2677798,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T12:37:09.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":8189,"price":4,"value":32756.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"1. These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1771262,"source":{"system":"sec-edgar","filing":"0001760460-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000004/primary_doc.xml","form_type":"4"}},{"id":2739700,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (Right to buy)","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":304286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":685236,"derivative":{"exercise_price":18.63,"exercise_date":"2018-03-29","expiration_date":"2022-09-29","underlying":"Common Stock","underlying_shares":304286},"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":2739699,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (Right to buy)","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":380950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":380950,"derivative":{"exercise_price":12,"exercise_date":"2016-11-29","expiration_date":"2023-11-29","underlying":"Common Stock","underlying_shares":380950},"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":2739698,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":609231,"price":4,"value":2436924.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1763077,"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":3137479,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T07:25:14.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":1153846,"price":13,"value":14999998.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1153846,"source":{"system":"sec-edgar","filing":"0001760460-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046020000002/primary_doc.xml","form_type":"4"}},{"id":3745921,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T10:14:33.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":4326,"price":1.21,"value":5234.46,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4601768,"source":{"system":"sec-edgar","filing":"0001733439-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000016/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-03"}},{"id":3745920,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T10:14:33.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":4326,"price":1.13,"value":4888.38,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4606094,"source":{"system":"sec-edgar","filing":"0001733439-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000016/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-03"}},{"id":3745919,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T09:39:59.000Z","date":"2018-11-29","kind":"sale","acquired":true,"shares":4326,"price":1.21,"value":5234.46,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4601768,"source":{"system":"sec-edgar","filing":"0001733439-18-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000015/primary_doc.xml","form_type":"4"}},{"id":3745918,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T09:39:59.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":4326,"price":1.13,"value":4888.38,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4606094,"source":{"system":"sec-edgar","filing":"0001733439-18-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000015/primary_doc.xml","form_type":"4"}}]}